Annual Net Income
-$22.93 M
+$10.65 M+31.72%
December 31, 2023
Summary
- As of February 7, 2025, CDTX annual net profit is -$22.93 million, with the most recent change of +$10.65 million (+31.72%) on December 31, 2023.
- During the last 3 years, CDTX annual net income has risen by +$49.18 million (+68.20%).
- CDTX annual net income is now -1606.18% below its all-time high of -$1.34 million, reached on December 31, 2013.
Performance
CDTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$15.98 M
+$75.22 M+82.47%
September 30, 2024
Summary
- As of February 7, 2025, CDTX quarterly net profit is -$15.98 million, with the most recent change of +$75.22 million (+82.47%) on September 30, 2024.
- Over the past year, CDTX quarterly net income has dropped by -$12.77 million (-397.51%).
- CDTX quarterly net income is now -206.72% below its all-time high of $14.98 million, reached on September 30, 2022.
Performance
CDTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$120.73 M
-$6.88 M-6.04%
September 30, 2024
Summary
- As of February 7, 2025, CDTX TTM net profit is -$120.73 million, with the most recent change of -$6.88 million (-6.04%) on September 30, 2024.
- Over the past year, CDTX TTM net income has dropped by -$97.80 million (-426.51%).
- CDTX TTM net income is now -16976.80% below its all-time high of -$707.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CDTX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.7% | -397.5% | -426.5% |
| 3 y3 years | +68.2% | -630.5% | -882.4% |
| 5 y5 years | +61.1% | -630.5% | -882.4% |
CDTX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.0% | -206.7% | +82.5% | -882.4% | at low |
| 5 y | 5-year | at high | +68.2% | -206.7% | +82.5% | -882.4% | at low |
| alltime | all time | -1606.2% | +68.2% | -206.7% | +82.5% | <-9999.0% | at low |
Cidara Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$15.98 M(-82.5%) | -$120.73 M(+6.0%) |
| Jun 2024 | - | -$91.21 M(+783.3%) | -$113.86 M(+213.9%) |
| Mar 2024 | - | -$10.33 M(+221.4%) | -$36.27 M(+58.2%) |
| Dec 2023 | -$22.93 M(-31.7%) | -$3.21 M(-64.7%) | -$22.93 M(-37.8%) |
| Sep 2023 | - | -$9.11 M(-33.2%) | -$36.88 M(+188.2%) |
| Jun 2023 | - | -$13.62 M(-552.2%) | -$12.79 M(+4.1%) |
| Mar 2023 | - | $3.01 M(-117.6%) | -$12.29 M(-63.4%) |
| Dec 2022 | -$33.58 M(-20.9%) | -$17.16 M(-214.6%) | -$33.58 M(+1.1%) |
| Sep 2022 | - | $14.98 M(-214.2%) | -$33.23 M(-49.9%) |
| Jun 2022 | - | -$13.12 M(-28.2%) | -$66.29 M(+56.1%) |
| Mar 2022 | - | -$18.28 M(+8.8%) | -$42.46 M(-0.0%) |
| Dec 2021 | -$42.47 M(-41.1%) | -$16.80 M(-7.1%) | -$42.47 M(-10.2%) |
| Sep 2021 | - | -$18.08 M(-268.8%) | -$47.30 M(+1.0%) |
| Jun 2021 | - | $10.71 M(-158.6%) | -$46.85 M(-38.2%) |
| Mar 2021 | - | -$18.29 M(-15.4%) | -$75.86 M(+5.2%) |
| Dec 2020 | -$72.11 M(+75.5%) | -$21.63 M(+22.7%) | -$72.11 M(+11.8%) |
| Sep 2020 | - | -$17.63 M(-3.7%) | -$64.50 M(+47.2%) |
| Jun 2020 | - | -$18.31 M(+25.9%) | -$43.83 M(+12.2%) |
| Mar 2020 | - | -$14.54 M(+3.7%) | -$39.07 M(-4.9%) |
| Dec 2019 | -$41.09 M | -$14.02 M(-561.4%) | -$41.09 M(+4.3%) |
| Sep 2019 | - | $3.04 M(-122.4%) | -$39.41 M(-29.7%) |
| Jun 2019 | - | -$13.55 M(-18.2%) | -$56.07 M(-4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$16.56 M(+34.2%) | -$58.83 M(-0.3%) |
| Dec 2018 | -$59.02 M(+5.9%) | -$12.34 M(-9.4%) | -$59.02 M(-1.8%) |
| Sep 2018 | - | -$13.62 M(-16.5%) | -$60.10 M(+2.3%) |
| Jun 2018 | - | -$16.31 M(-2.6%) | -$58.74 M(-0.6%) |
| Mar 2018 | - | -$16.75 M(+24.7%) | -$59.08 M(+6.0%) |
| Dec 2017 | -$55.73 M(+15.7%) | -$13.43 M(+9.6%) | -$55.73 M(-1.7%) |
| Sep 2017 | - | -$12.26 M(-26.4%) | -$56.69 M(+0.1%) |
| Jun 2017 | - | -$16.64 M(+24.2%) | -$56.66 M(+9.4%) |
| Mar 2017 | - | -$13.40 M(-6.9%) | -$51.77 M(+7.5%) |
| Dec 2016 | -$48.16 M(+49.6%) | -$14.39 M(+17.7%) | -$48.16 M(+10.4%) |
| Sep 2016 | - | -$12.23 M(+4.0%) | -$43.64 M(+7.5%) |
| Jun 2016 | - | -$11.76 M(+20.1%) | -$40.59 M(+15.2%) |
| Mar 2016 | - | -$9.79 M(-0.8%) | -$35.24 M(+9.5%) |
| Dec 2015 | -$32.19 M(+170.7%) | -$9.87 M(+7.6%) | -$32.19 M(+19.3%) |
| Sep 2015 | - | -$9.17 M(+43.0%) | -$26.97 M(+27.7%) |
| Jun 2015 | - | -$6.41 M(-4.8%) | -$21.12 M(+17.8%) |
| Mar 2015 | - | -$6.74 M(+44.9%) | -$17.92 M(+50.7%) |
| Dec 2014 | -$11.89 M(+785.0%) | -$4.65 M(+40.1%) | -$11.89 M(+64.2%) |
| Sep 2014 | - | -$3.32 M(+3.1%) | -$7.25 M(+84.5%) |
| Jun 2014 | - | -$3.22 M(+355.3%) | -$3.93 M(+455.3%) |
| Mar 2014 | - | -$707.00 K | -$707.00 K |
| Dec 2013 | -$1.34 M | - | - |
FAQ
- What is Cidara Therapeutics annual net profit?
- What is the all time high annual net income for Cidara Therapeutics?
- What is Cidara Therapeutics annual net income year-on-year change?
- What is Cidara Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly net income year-on-year change?
- What is Cidara Therapeutics TTM net profit?
- What is the all time high TTM net income for Cidara Therapeutics?
- What is Cidara Therapeutics TTM net income year-on-year change?
What is Cidara Therapeutics annual net profit?
The current annual net income of CDTX is -$22.93 M
What is the all time high annual net income for Cidara Therapeutics?
Cidara Therapeutics all-time high annual net profit is -$1.34 M
What is Cidara Therapeutics annual net income year-on-year change?
Over the past year, CDTX annual net profit has changed by +$10.65 M (+31.72%)
What is Cidara Therapeutics quarterly net profit?
The current quarterly net income of CDTX is -$15.98 M
What is the all time high quarterly net income for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly net profit is $14.98 M
What is Cidara Therapeutics quarterly net income year-on-year change?
Over the past year, CDTX quarterly net profit has changed by -$12.77 M (-397.51%)
What is Cidara Therapeutics TTM net profit?
The current TTM net income of CDTX is -$120.73 M
What is the all time high TTM net income for Cidara Therapeutics?
Cidara Therapeutics all-time high TTM net profit is -$707.00 K
What is Cidara Therapeutics TTM net income year-on-year change?
Over the past year, CDTX TTM net profit has changed by -$97.80 M (-426.51%)